Variants of LRP2, encoding a multifunctional cell-surface endocytic receptor, associated with hearing loss and retinal dystrophy
- PMID: 36807241
- PMCID: PMC11330644
- DOI: 10.1111/cge.14312
Variants of LRP2, encoding a multifunctional cell-surface endocytic receptor, associated with hearing loss and retinal dystrophy
Abstract
Hereditary deafness and retinal dystrophy are each genetically heterogenous and clinically variable. Three small unrelated families segregating the combination of deafness and retinal dystrophy were studied by exome sequencing (ES). The proband of Family 1 was found to be compound heterozygous for NM_004525.3: LRP2: c.5005A > G, p.(Asn1669Asp) and c.149C > G, p.(Thr50Ser). In Family 2, two sisters were found to be compound heterozygous for LRP2 variants, p.(Tyr3933Cys) and an experimentally confirmed c.7715 + 3A > T consensus splice-altering variant. In Family 3, the proband is compound heterozygous for a consensus donor splice site variant LRP2: c.8452_8452 + 1del and p.(Cys3150Tyr). In mouse cochlea, Lrp2 is expressed abundantly in the stria vascularis marginal cells demonstrated by smFISH, single-cell and single-nucleus RNAseq, suggesting that a deficiency of LRP2 may compromise the endocochlear potential, which is required for hearing. LRP2 variants have been associated with Donnai-Barrow syndrome and other multisystem pleiotropic phenotypes different from the phenotypes of the four cases reported herein. Our data expand the phenotypic spectrum associated with pathogenic variants in LRP2 warranting their consideration in individuals with a combination of hereditary hearing loss and retinal dystrophy.
Keywords: Donnai-Barrow syndrome; LRP2; RNAseq; deafness; megalin; retinal dystrophy; stria vascularis.
© 2023 John Wiley & Sons Ltd. This article has been contributed to by U.S. Government employees and their work is in the public domain in the USA.
Conflict of interest statement
CONFLICT OF INTEREST STATEMENT
The authors declare there is no potential conflict of interest.
Figures
References
-
- Griffith AJ, Friedman TB. Hereditary hearing loss. Ballenger’s Otorhinolaryngology Head and Neck Surgery. 18th ed. People’s Medical Publishing House; 2016:329–345.
Publication types
MeSH terms
Substances
Grants and funding
- R29 DC003594/DC/NIDCD NIH HHS/United States
- R01 DC011651/DC/NIDCD NIH HHS/United States
- R01 DC000086/DC/NIDCD NIH HHS/United States
- R01 DC003594/DC/NIDCD NIH HHS/United States
- ZIA DC000088/ImNIH/Intramural NIH HHS/United States
- T32 DC000039/DC/NIDCD NIH HHS/United States
- R01 DC017712/DC/NIDCD NIH HHS/United States
- Z01 DC000039/ImNIH/Intramural NIH HHS/United States
- WT_/Wellcome Trust/United Kingdom
- U01 HG009716/HG/NHGRI NIH HHS/United States
- Z01 DC000060/ImNIH/Intramural NIH HHS/United States
- R01 DC016593/DC/NIDCD NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
